| Patent | Date |
|---|
Glycan-interacting compounds and methods of use
Grant 11,401,330 - Eavarone , et al. August 2, 2 | 2022-08-02 |
Glycan-interacting Compounds And Methods Of Use
App 20190276541 - Eavarone; David A. ; et al. | 2019-09-12 |
Glycan-interacting Compounds And Methods Of Use
App 20180327509 - Eavarone; David A. ; et al. | 2018-11-15 |
Disulfide-stabilized Fabs
App 20180271998 - DRUMMOND; Daryl C. ; et al. | 2018-09-27 |
Combination Cancer Therapies
App 20180169230 - ADAMS; Sharlene ; et al. | 2018-06-21 |
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
Grant 9,938,346 - Baum , et al. April 10, 2 | 2018-04-10 |
Dosage And Administration Of Monospecific And Bispecific Anti-igr-1r And Anti-erbb3 Antibodies
App 20180036395 - LUGOVSKOY; Alexey Alexandrovich ; et al. | 2018-02-08 |
Glycan-interacting compounds and methods of use
Grant 9,879,087 - DeSander , et al. January 30, 2 | 2018-01-30 |
Cartilage-binding Fusion Proteins
App 20170327556 - FLORINE; Emily ; et al. | 2017-11-16 |
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof
App 20170314079 - BUKHALID; Raghida ; et al. | 2017-11-02 |
Glycan-interacting Compounds And Methods Of Use
App 20170306046 - daSilva; Ana Paula Galvao ; et al. | 2017-10-26 |
Dosage And Administration Of Combination Therapies Comprising Istiratumab, Uses And Methods Of Treatment
App 20170233491 - LUGOVSKOY; Alexey Alexandrovich ; et al. | 2017-08-17 |
Bispecific Binding Agents Targeting The Igf-1r And Erbb3 Pathways And Uses Thereof
App 20170210809 - SCHOEBERL; Birgit ; et al. | 2017-07-27 |
DOSAGE AND ADMINISTRATION OF ANTI-IGF-1R, ANTI-ErbB3 BISPECIFIC ANTIBODIES, USES THEREOF AND METHODS OF TREATMENT THEREWITH
App 20170096492 - ADAMS; Sharlene ; et al. | 2017-04-06 |
Anti-c-met Tandem Fc Bispecific Antibodies
App 20170081421 - HARMS; Brian ; et al. | 2017-03-23 |
Monospecific And Bispecific Anti-igf-1r And Anti-erbb3 Antibodies
App 20170051063 - BAUM; Jason ; et al. | 2017-02-23 |
Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies
Grant 9,556,274 - Baum , et al. January 31, 2 | 2017-01-31 |
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
Grant 9,527,914 - Baum , et al. December 27, 2 | 2016-12-27 |
Monospecific And Bispecific Anti-igf-1r And Anti-erbb3 Antibodies
App 20160137738 - Baum; Jason ; et al. | 2016-05-19 |
Monospecific And Bispecific Anti-igf-1r And Anti-erbb3 Antibodies
App 20160122438 - BAUM; Jason ; et al. | 2016-05-05 |
Dosage And Administration Of Monospecific And Bispecific Anti-igr-1r And Anti-erbb3 Antibodies
App 20150231219 - Lugovskoy; Alexey Alexandrovich ; et al. | 2015-08-20 |
Stabilized polypeptide compositions
Grant 8,892,364 - Glaser , et al. November 18, 2 | 2014-11-18 |
Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
Grant 08618252 - | 2013-12-31 |
Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
Grant 8,618,252 - Farrington , et al. December 31, 2 | 2013-12-31 |
Monospecific And Bispecific Anti-igf-1r And Anti-erbb3 Antibodies
App 20130236459 - BAUM; Jason ; et al. | 2013-09-12 |
Bispecific anti-IGF-1R and anti-ErbB3 antibodies
Grant 8,476,409 - Baum , et al. July 2, 2 | 2013-07-02 |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
Grant 8,349,324 - Lugovskoy , et al. January 8, 2 | 2013-01-08 |
Monospecific And Bispecific Anti-igf-1r And Anti-erbb3 Antibodies
App 20120269812 - BAUM; Jason ; et al. | 2012-10-25 |
Bispecific Binding Agents Targeting Igf-1r And Erbb3 Signalling And Uses Thereof
App 20120244163 - SCHOEBERL; Birgit ; et al. | 2012-09-27 |
NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
App 20120003210 - FARRINGTON; Graham K. ; et al. | 2012-01-05 |
SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO
App 20110243966 - FARRINGTON; Graham K. ; et al. | 2011-10-06 |
Cripto binding molecules
Grant 8,021,661 - Glaser , et al. September 20, 2 | 2011-09-20 |
Stabilized polypeptide compositions
Grant 7,960,142 - Glaser , et al. June 14, 2 | 2011-06-14 |
Stabilized polypeptide compositions
Grant 7,951,918 - Glaser , et al. May 31, 2 | 2011-05-31 |
Methods of Humanizing Immunoglobulin Variable Regions Through Rational Modification Of Complementarity Determining Residues
App 20100093980 - Lugovskoy; Alexey Alexandrovich ; et al. | 2010-04-15 |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
Grant 7,678,371 - Lugovskoy , et al. March 16, 2 | 2010-03-16 |
Cripto binding molecules
App 20100008906 - Glaser; Scott ; et al. | 2010-01-14 |
Altered polypeptides, immunoconjugates thereof, and methods related thereto
App 20090258420 - van Vlijmen; Herman ; et al. | 2009-10-15 |
Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
App 20090252729 - Farrington; Graham K. ; et al. | 2009-10-08 |
Cd23 Binding Molecules And Methods Of Use Thereof
App 20090155255 - Glaser; Scott ; et al. | 2009-06-18 |
Compositions That Bind Multiple Epitopes Of Igf-1r
App 20090130105 - Glaser; Scott ; et al. | 2009-05-21 |
Stabilized polypeptide compositions
App 20090048122 - Glaser; Scott ; et al. | 2009-02-19 |
Modular molecular clasps and uses thereof
App 20070276129 - Rizzuto; Carlo Dante ; et al. | 2007-11-29 |
Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
App 20070148164 - Farrington; Graham K. ; et al. | 2007-06-28 |
Altered antibodies having improved antigen-binding affinity
App 20070135998 - Van Vlijmen; Herman ; et al. | 2007-06-14 |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
App 20060258852 - Lugovskoy; Alexey Alexandrovich ; et al. | 2006-11-16 |
Modular molecular clasps and uses thereof
App 20020192721 - Rizzuto, Carlo Dante ; et al. | 2002-12-19 |
| 